Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Equillium, Inc., a biotechnology company focused on therapies for autoimmune and inflammatory disorders, announced its management team's participation in a fireside chat at Stifel's 2026 Virtual Immunology and Inflammation Forum. The event will provide investor engagement opportunities and a live webcast of the discussion.
CTW, a Tokyo-based game platform company trading on Nasdaq, announced that CFO Patrick Liu will participate in a virtual fireside chat hosted by Alliance Global Partners on September 23, 2026. The discussion will cover CTW's flagship platform G123.jp, licensed anime intellectual properties, browser-based gaming model economics, and efforts to expan…
Propanc Biopharma presents a comparative analysis positioning its lead candidate PRP as a complementary therapy to FDA-approved and investigational RAS inhibitors from Revolution Medicines and Erasca. PRP, a proenzyme combo, targets epithelial-mesenchymal transition (EMT), cancer stem cells, and tumor microenvironment remodeling, addressing resista…
Amaze Holdings, Inc. announces a new mutual referral partnership with C2 Live Inc., enhancing revenue opportunities for both platforms' creator and audience ecosystems. This collaboration builds on a previous strategic investment to enable cross-promotion, expanding monetization and engagement across Amaze's 14 million creator storefronts and C2's …
Nuwellis, a medical technology company specializing in cardiorenal patient solutions, announced the hiring of Brian Johnson as Director of Quality and Regulatory Affairs. Johnson brings significant experience in medical device regulation and quality management, aimed at strengthening Nuwellis' capabilities in product development, commercialization,…
Antelope Enterprise Holdings Limited announced the closing of a $6 million offering of 8% convertible promissory notes to an accredited investor. The proceeds will support the company’s livestreaming e-commerce operations in China. The notes bear interest at 8% annually, are convertible into Class A shares at a discount to market price with ownersh…
Oragenics announced that its Chief Medical Officer will present at the IPAC-RS 2026 Nasal Innovation Forum, highlighting the clinical development and intranasal delivery technology of ONP-002, a first-in-class neurosteroid candidate for concussion treatment. The ongoing Phase IIa trial in Australia and anticipated U.S. IND submission in Q4 2026 wer…
Autonomix Medical, a Nasdaq-listed medical device company specializing in nerve-targeted treatments, announced the appointment of Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel at Medtronic, to its Board of Directors. Kalter brings over 40 years of expertise in MedTech leadership, regulatory strategy, clinical development, …
Orchestra BioMed announced that its investigational AVIM Therapy for uncontrolled hypertension will be featured in two sessions at the HRX Live 2026 conference, including a roundtable focusing on their collaboration with Medtronic to advance development and commercialization. The sessions will highlight AVIM Therapy's potential to reduce blood pres…
Liberty Defense announced a new commercial agreement to deploy its HEXWAVE AI-based concealed weapon detection systems at multiple U.S. logistics and manufacturing facilities starting in 2026. The deployment includes a financing option for commercial customers and aims to protect both employees and assets by detecting metallic and non-metallic thre…
DLH Holdings Corp. has secured a follow-on task order from the National Heart, Lung, and Blood Institute valued at up to $43.7 million over two and a half years. The contract builds upon DLH's prior work since 2018, focusing on AI operations and automation to enhance IT services, cybersecurity, and infrastructure for around 2,000 NHLBI employees an…
FG Nexus announces its Board has approved a strategic shift to acquire affordable housing communities and a $10 million investment in FG Communities, a privately held operator of manufactured housing communities. The company plans to directly acquire land-lease affordable housing properties, fund acquisitions via cash, debt, and equity, and intends…
Critical Metals Corp reported significant advancements in its mine-to-metals strategy for the Tanbreez Rare Earth Project in Greenland. The company highlights a novel refinery process in Romania expected to produce ultra-high purity rare earth products and valuable silica by-products, potentially generating annual revenues between $1.8–2.2 billion.…
Rocky Mountain Chocolate Factory announces a limited-edition Miso Caramel Apple in partnership with Miraculous Corp to introduce a unique sweet-savory flavor and leverage the popular Miraculous franchise. This initiative aims to attract new customers, enhance in-store experiences, and drive sales through innovative product offerings tied to a globa…
PMA Graphene Technology Group Inc., listed on NASDAQ, announced that Mr. Zhijun Pan has resigned as CEO effective immediately due to personal commitments. Mr. Lei Liu has been appointed as the new CEO. The company, based in Hong Kong, provides wet trades services and also operates graphene thermal management technology through a subsidiary.
Cuprina Holdings (Cayman) Limited, a Nasdaq-listed biomedical company focused on chronic wounds, infertility, medical waste recycling, and cosmeceuticals, announced the pricing of a $4.97 million public offering of 4.3 million Class A shares at $1.15 each, with an overallotment option increasing proceeds to approximately $5.72 million. The offering…
Optimi Health Corp., a pharmaceutical company specializing in regulated psychedelic drug products, announced plans to begin a Health Canada-authorized Phase 3 clinical trial in 2027 evaluating MDMA-assisted therapy for PTSD. The trial will enroll up to 100 participants, focusing on veterans and frontline workers. This follows Optimi's recent Phase …
MAIA Biotechnology has dosed the first U.S. patient in the Phase 2 THIO-101 clinical trial evaluating its lead drug candidate, ateganosine, for third-line treatment of non-small cell lung cancer (NSCLC). This expansion follows FDA clearance and is funded by a $2.3 million NIH grant. Prior data shows promising survival outcomes, and the trial aims t…
VivoSim Labs presented new clinical benchmark data for its NAMkind™ 3D human liver and intestinal platforms at EUROTOX 2026. The data demonstrate superior predictive ability for drug toxicity across small molecules and antibody-drug conjugates (ADCs), particularly in assessing liver and gastrointestinal safety. The technology helps pharmaceutical c…
Royal Philips announced that two of its collaborations, SYMPHONY and AI FORSchung, received prestigious ITEA Awards of Excellence 2026 for their advancements in AI-enabled healthcare technologies. SYMPHONY connects healthcare data and clinical workflows through interoperable ecosystems, supporting multiple diseases with FDA-cleared technology. AI F…
Stellantis announced it will showcase nine concept cars from eight of its brands along with over 60 vehicles at the Paris Motor Show in October 2026. This event underscores the company’s renewed ambition under its FaSTLAne 2030 strategic plan, featuring international premieres including electric and hybrid models from brands such as DS Automobiles,…
SHF Holdings, Inc. (Safe Harbor) announced it was named Top Business Solutions Company at the 2026 PBC Cannabis Banking Conference. The company, a leading provider of cannabis banking infrastructure and compliance solutions, highlighted its role as the official cannabis banking solutions sponsor and its expertise in helping financial institutions m…
Myriad Genetics appointed Vishal Sikri as Executive Vice President - Commercial, reflecting confidence in his leadership to drive growth and execute the company's cancer care continuum and profitability strategy. The company also reaffirmed its full-year 2026 financial guidance.
Seer, Inc. announced that its Proteograph Product Suite has been used in over 100 peer-reviewed scientific studies worldwide, validating its technology as a breakthrough for deep, unbiased proteomics at scale. This milestone underscores the platform's capability to analyze large biological datasets with improved depth, speed, and reproducibility, e…
IperionX Limited has successfully validated its next-generation GenX™ continuous HAMR™ titanium production platform, achieving significant improvements over traditional batch processing. The continuous process delivers six times higher throughput with substantially lower consumption of key inputs such as magnesium, hydrogen, and power. Product samp…
